Evolving regulatory landscape with erythropoiesis-stimulating agents and impact on managed care.

Fatodu, Hugh

Evolving regulatory landscape with erythropoiesis-stimulating agents and impact on managed care. [electronic resource] - The American journal of managed care Mar 2010 - S74-9 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1936-2692


Anemia--drug therapy
Cardiovascular Diseases--chemically induced
Drug and Narcotic Control
Drug-Related Side Effects and Adverse Reactions
Hematinics--adverse effects
Humans
Insurance, Health, Reimbursement
Kidney Failure, Chronic--complications
Managed Care Programs
Neoplasms--complications
Product Surveillance, Postmarketing
Risk Assessment
Stroke--chemically induced
United States--epidemiology
United States Food and Drug Administration